EUVIMEDEUVIMED entdecken
Crossref

Precision in practice: a new standard in early-relapsing HR+ breast cancer

Nathalie LeVasseur, Karen A. Gelmon

AME Clinical Trials Review · 2026-06 · 4 · 27-27

DOI: 10.21037/actr-25-112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AME Clinical Trials Review, 2026-06. Verfasst von Nathalie LeVasseur und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

LeVasseur, N., & Gelmon, K. A. (2026). Precision in practice: a new standard in early-relapsing HR+ breast cancer. AME Clinical Trials Review, 4, 27-27. https://doi.org/10.21037/actr-25-112

Vancouver

LeVasseur N, Gelmon KA. Precision in practice: a new standard in early-relapsing HR+ breast cancer. AME Clinical Trials Review. 2026;4:27-27. doi:10.21037/actr-25-112

BibTeX
@article{LeVasseur2026,
  author = {LeVasseur, Nathalie and Gelmon, Karen A.},
  title = {Precision in practice: a new standard in early-relapsing HR+ breast cancer},
  journal = {AME Clinical Trials Review},
  year = {2026},
  volume = {4},
  pages = {27--27},
  doi = {10.21037/actr-25-112}
}
Kostenlos starten →